Yestar Healthcare Holdings Company Limited provided earnings guidance for the year ended 31 December 2023. The Group is expected to record a significant decrease in net loss of the Group to not more than approximately RMB 10 million for year 2023 as compared to the audited consolidated net loss of the Group of approximately RMB 1,021 million for the year ended 31 December 2022.